Alcon (ALC) EBITDA Margin (2009 - 2026)
Alcon (ALC) posted EBITDA Margin of 0.4% for Q2 2026, down 96.36% on a QoQ basis from 10.88% in Q1 2026, and down 919.0% year-over-year from 0.05% in Q2 2025.
Powered by 
Analysis
Alcon (ALC) EBITDA Margin (2009 - 2026) Analysis & Trends
Alcon has reported EBITDA Margin for 11 years, with the latest figure at 0.4% in Q2 2026.
- On a quarterly basis, EBITDA Margin fell 919.0% year-over-year to 0.4% in Q2 2026; TTM through Jun 2026 was 8.81%, a 415.0% decrease from a year earlier, with the FY2025 full-year figure at 13.18%, up 280.0% from the prior year.
- EBITDA Margin was 0.4% for Q2 2026 at Alcon, down from 10.88% in the prior quarter.
- The five-year high for EBITDA Margin was 15.95% in Q4 2024, with the low at 8.15% in Q4 2022.
- Average EBITDA Margin over 5 years is 9.31%, with a median of 11.24% recorded in 2022.
- The sharpest annual moves came in 2024 and 2026: EBITDA Margin jumped 1719 bps in 2024, then sank 919 bps in 2026.
- Over 5 years, EBITDA Margin stood at 8.15% in 2022, then soared by 85 bps to 1.24% in 2023, then jumped by 1382 bps to 15.95% in 2024, then decreased by 27 bps to 11.58% in 2025, then plunged by 97 bps to 0.4% in 2026.
- The last three EBITDA Margin figures came in at 0.4% (Q2 2026), 10.88% (Q1 2026), and 11.58% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 19.15% |
| 10 | Zimmer Biomet Holdings | 18.70 Bn | 18.30 Bn | 1.54 Bn | 14.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.40% |
| Mar 31, 2026 | 10.88% |
| Dec 31, 2025 | 11.58% |
| Sep 30, 2025 | 12.82% |
| Jun 30, 2025 | 9.58% |
| Dec 31, 2024 | 15.95% |
| Sep 30, 2024 | 13.65% |
| Jun 30, 2024 | 12.81% |
| Mar 31, 2024 | 15.06% |
| Dec 31, 2023 | -1.24% |
| Sep 30, 2023 | 12.58% |
| Jun 30, 2023 | 11.15% |
| Mar 31, 2023 | 11.39% |
| Dec 31, 2022 | -8.15% |
| Sep 30, 2022 | 9.58% |
| Jun 30, 2022 | 9.02% |
| Mar 31, 2022 | 11.24% |
| Dec 31, 2021 | -0.56% |
| Sep 30, 2021 | 0.95% |
| Jun 30, 2021 | 10.85% |